Cargando…
Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population
BACKGROUND: Addressing the burden of HPV-associated diseases among men is increasingly becoming a public health issue. The main objective of this study was to determine HPV prevalence among a healthy community-based Malaysian men. METHOD: This was a cross-sectional study that recruited 503 healthy m...
Autores principales: | Khoo, Su Pei, Shafii, Mohd Khairul Anwar, Bhoo-Pathy, Nirmala, Yap, Siew Hwei, Subramaniam, Shridevi, Nasir, Nazrila Hairizan, Lin, Zhang, Belinson, Jerome, Goh, Pik Pin, Qu, Xinfeng, Gravitt, Patti, Woo, Yin Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817061/ https://www.ncbi.nlm.nih.gov/pubmed/33471825 http://dx.doi.org/10.1371/journal.pone.0245731 |
Ejemplares similares
-
Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women
por: Ma'som, Mahirah, et al.
Publicado: (2016) -
Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program
por: Khoo, Su Pei, et al.
Publicado: (2022) -
Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country
por: Kong, Yek-Ching, et al.
Publicado: (2017) -
The association between methods of biopsy and survival following breast cancer: A hospital registry based cohort study
por: Kong, Yek-Ching, et al.
Publicado: (2020) -
Association between pre-existing cardiometabolic comorbidities and the pathological profiles of breast cancer at initial diagnosis: a cross sectional study
por: Subramaniam, Shridevi, et al.
Publicado: (2023)